ASK 1 Monoclonal Antibody

Mitogen-activated protein kinase (MAPK) signaling cascades include MAPK or extracellular signal-regulated kinase (ERK), MAPK kinase (MKK or MEK), and MAPK kinase kinase (MAPKKK or MEKK). MAPKK kinase/MEKK phosphorylates and activates its downstream protein kinase, MAPK kinase/MEK, which in turn activates MAPK. The kinases of these signaling cascades are highly conserved, and homologs exist in yeast, Drosophila, and mammalian cells. MAPKKK5 contains 1,374 amino acids with all 11 kinase subdomains. Northern blot analysis shows that MAPKKK5 transcript is abundantly expressed in human heart and pancreas. The MAPKKK5 protein phosphorylates and activates MKK4 (aliases SERK1, MAPKK4) in vitro, and activates c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) during transient expression in COS and 293 cells; MAPKKK5 does not activate MAPK/ERK.

Introducing ASK 1 Monoclonal Antibody, a highly effective and reliable solution for targeted therapy. This innovative product is designed to specifically target and neutralize the ASK 1 protein, a key mediator of cellular stress response pathways. ASK 1 Monoclonal Antibody is produced using state-of-the-art technology and is rigorously tested to ensure purity, potency, and consistency.

With its exceptional specificity and affinity, ASK 1 Monoclonal Antibody offers a powerful tool for researchers and clinicians seeking to investigate the role of ASK 1 in disease pathogenesis and develop novel therapeutic strategies. Its unique mechanism of action makes it an ideal candidate for the treatment of a wide range of diseases, including cancer, neurodegenerative disorders, and inflammatory conditions.

In addition to its outstanding therapeutic potential, ASK 1 Monoclonal Antibody is also highly versatile and can be used in a variety of applications, including Western blotting, immunoprecipitation, and immunohistochemistry. Its high sensitivity and low background make it an excellent choice for detecting and quantifying ASK 1 expression in various tissues and cell types.

Overall, ASK 1 Monoclonal Antibody represents a cutting-edge solution for targeted therapy and research, offering unparalleled specificity, potency, and versatility. Its exceptional quality and performance make it a valuable addition to any laboratory or clinical setting.